Summary of in vitro genetic toxicology assay results: Expected and unexpected effects of recent study design modifications

Environmental and Molecular Mutagenesis

Volumn 53, Issue 8, 2012, Pages 631-635

  Clarke, Jane J ^a   Lawlor, Timothy E ^a   Madraymootoo, Wannie ^a   Pant, Kamala ^a   Young, Robert R ^a   Wagner, Valentine O ^a   Aardema, Marilyn J ^a  

^a BioReliance by SAFC   (United States)

Author keywords

Chromosome aberration; Genetic toxicology; Mutation

Indexed keywords

PROTEIN P53;

AMES TEST; ANIMAL CELL; ARTICLE; ASSAY; CELL COUNT; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; CYTOTOXICITY; GENE MUTATION; GENETIC TOXICOLOGY; GENOTOXICITY; GOOD LABORATORY PRACTICE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA; MAMMAL CELL; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CHO CELLS; CHROMOSOME ABERRATIONS; CRICETINAE; CRICETULUS; DNA DAMAGE; HUMANS; LYMPHOCYTES; MUTAGENICITY TESTS;

CRICETULUS GRISEUS;

EID: 84867395411     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21733     Document Type: Article

References (21)

1. Ames BN, McCann J, Yamasaki E. 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat Res 31: 347-364.
2. Clive D, Spector JFS. 1975. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutat Res 31: 17-29.
3. Clive D, Bolcsfoldi G, Clements J, Cole J, Honma M, Majeska J, Moore M, Muller L, Myhr B, Oberly T, Oudelhkim M, Rudd C, Shimada H, Sofuni T, Thybaud V, Wilcox P. 1995. Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ Mol Mutagen 25: 165-168.
4. Evans HJ. 1976. Cytological methods for detecting chemical mutagens. In: Hollaender A, editor. Chemical Mutagens, Principles and Methods for their Detection, Vol. 4. New York: Plenum Press. pp 1-29.
5. Evans HJ, O'Riordan ML. 1975. Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutat Res 31: 135-148.
6. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals. S2A document recommended for adoption at step 4 of the ICH process on July 19, 1995. Federal Register 61:18198-18202, April 24, 1996.
7. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals. S2B document recommended for adoption at step 4 of the ICH process on July 16, 1997. Federal Register 62:16026-16030, November 21, 1997.
8. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. Guideline S2 (R1) recommended for adoption at step 4 of the ICH process on November 9, 2011. Adopted at Step 5 in Europe by CHMP December 2011 (issued as EMA/CHMP/ICH/126642/2008). Adopted at Step 5 in US by FDA on June 7, 2012 (issued as 77 FR 33748 pages 33748-33749). Japan Step 5 adoption in process.
9. Kirkland DJ, Aardema MJ, Banduhn N, Carmichael P, Fautz R, Meunier J-R, Pfuhler S. 2007a. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. Mutagenesis 22: 161-175.
10. Kirkland DJ, Hayashi M, Jacobson-Kram D, Kasper P, MacGregor JT, Muller L, Uno Y. 2007b. Summary of major conclusions of the 4th IWGT, San Francisco, 9-10 September, 2005. Mutat Res 627: 5-9.
11. Kirkland DJ, Hayashi M, Jacobson-Kram D, Kasper P, Gollapudi B, Muller L, Uno Y. 2011. Summary of major conclusions of the 5th IWGT, Basel, Switzerland, 17-19 August 2009. Mutat Res 723: 73-76.
12. Maron DM, Ames BN. 1983. Revised methods for the Salmonella mutagenicity test. Mutat Res 113: 173-215.
13. +/- mouse lymphoma specific gene and chromosomal mutation assay. A phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 394: 177-303.
14. Moore MM, Honma M, Clements J, Harrington-Brock K, Awogi T, Bolcsfoldi G, Cifone M, Collard D, Fellows M, Flanders K, Gollapudi B, Jenkinson P, Kirby PE, Kirchner S, Kraycer J, McEnaney S, Muster W, Myhr BC, O'Donovan M, Oliver J, Ouldelhkim M, Pant K, Preston R, Riach C, San R, Shimada H, Stankowski LFJr. 2002. Mouse lymphoma thymidine kinase gene mutation assay: Follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000. Environ Mol Mutagen 40: 292-299.
15. Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Delongschamp R, Durward R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Loyd M, Majeska J, Myhr BC, O'Donovan M, Omori T, Riach C, San R, Stankowski LFJr, Thakur A, Van Goethem F, Wakuri S, Yoshimura I. 2006. Mouse lymphoma thymidine kinase gene mutation assay: Follow-up Meeting of the International Workshop on Genotoxicity Testing, Aberdeen, Scotland, 2003, Assay Acceptance Criteria, Positive Controls, and Data Evaluation. Environ Mol Mutagen 47: 1-5.
16. Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Clay P, Doppalapudi R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Kidd D, Lorge E, Loyd M, Muster W, Myhr BC, O'Donovan M, Omori T, Pant K, Riach C, Stankowski LFJr, Thakur A, Van Goethem F, Wakuri S, Yoshimura I. 2007. Mouse lymphoma thymidine kinase gene mutation assay: Meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005 recommendations for 24-hour treatment. Mutat Res 627: 36-40.
17. OECD Guideline for the Testing of Chemicals, Guideline 471 (Bacterial Reverse Mutation Test), Ninth Addendum to the OECD Guidelines for the Testing of Chemicals, adopted July 21, 1997.
18. OECD Guideline for the Testing of Chemicals, Guideline 473 (In Vitro Mammalian Chromosome Aberration Test), Ninth Addendum to the OECD Guidelines for the Testing of Chemicals, published by OECD, Paris, February 1998a.
19. OECD Guideline for the Testing of Chemicals, Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test), Ninth Addendum to the OECD Guidelines for the Testing of Chemicals, published by OECD, Paris, February 1998b.
20. Seifried HE, Seifried RM, Clarke JJ, Junghans TB, San RHC. 2006. A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays. Chem Res Toxicol 19: 627-644.
21. Thybaud V, Aardema MJ, Casciano D, Dellarco V, Embry MR, Gollapudi BB, Hayashi M, Holsapple MP, Jacobson-Kram D, Kasper P, MacGregor JT, Rees R. 2007. Relevance and follow-up of positive results in in vitro genetic toxicity assays: An ILSI-HESI perspective. Mutat Res 633: 67-79.